Search Results - "Elena V. Esaulenko"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    CX3CL1/Fractalkine: A Potential Biomarker for Liver Fibrosis in Chronic HBV Infection by Arsentieva, Natalia A, Korobova, Zoia R, Batsunov, Oleg K, Lyubimova, Natalia E, Basina, Valentina V, Esaulenko, Elena V, Totolian, Areg A

    Published in Current issues in molecular biology (10-09-2024)
    “…A hepatitis B virus (HBV) infection can progress to chronic hepatitis, leading to liver fibrosis, cirrhosis, and hepatocellular carcinoma. CX3CL1/Fractalkine…”
    Get full text
    Journal Article
  2. 2

    A new approach to etiotropic therapy ARVI in children by Sabitov, A U, Kovtun, O P, Esaulenko, E V, Sorokin, P V

    Published in Terapevtic̆eskii arhiv (26-12-2022)
    “…Confirmation of the efficacy and safety of the drug riamilovir (Triazavirin ), 100 mg capsules, in children aged 12-17 years with the diagnosis of acute viral…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation by Esaulenko, Elena V, Yakovlev, Aleksey A, Volkov, Genady A, Sukhoruk, Anastasia A, Surkov, Kirill G, Kruglyakov, Peter V, Diaz-Mitoma, Francisco

    Published in Clinical infectious diseases (02-11-2021)
    “…Abstract Background This study compares the immunogenicity and safety of a 3-antigen (S/pre-S1/pre-S2) hepatitis B (HepB) vaccine (3AV), to a single antigen…”
    Get full text
    Journal Article
  5. 5

    Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19 by Sabitov, A U, Lioznov, D A, Zhdanov, K V, Tihonova, E P, Esaulenko, E V, Sorokin, P V

    Published in Terapevtic̆eskii arhiv (16-04-2024)
    “…Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial by Kalyuzhin, O V, Gorelov, A V, Malyavin, A G, Zaytsev, A A, Esaulenko, E V, Novak, K E, Bykov, A S

    Published in Terapevtic̆eskii arhiv (23-11-2023)
    “…To evaluate the efficacy and safety of OM-85 in the treatment of uncomplicated acute respiratory infections (ARI) in adults. A double-blind,…”
    Get full text
    Journal Article
  8. 8

    Epidemiology and course of infectious diseases during the COVID-19 pandemic. Report 1. HIV infection, hepatitis c and tuberculosis by Belyakov, Nikolay A., Boeva, Ekaterina V., Zagdyn, Zinaida M., Esaulenko, Elena V., Lioznov, Dmitry A., Simakina, Olga E.

    Published in Infekt͡s︡ii͡a︡ i immunitet (15-11-2022)
    “…Pathological conditions of various natures are capable of mutual aggravation, significantly affecting the overall burden of the disease, its manifestations and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Association between Higher CD32a+CD4+ T Cell Count and Viral Load in the Peripheral Blood of HIV-infected Patients by Arsentieva, Natalia A., Batsunov, Oleg K., Semenov, Alexander V., Kudryavtsev, Igor V., Esaulenko, Elena V., Boeva, Ekaterina V., Kovelenov, Alexey Y., Totolian, Areg A.

    Published in The open AIDS journal (13-07-2021)
    “…Background: The significance of CD32a receptor expression in individuals infected with Human Immunodeficiency Virus (HIV) is currently unclear. Previously, B…”
    Get full text
    Journal Article
  11. 11

    Birch bark extract as therapy for chronic hepatitis C – A pilot study by Shikov, Alexander N., Djachuk, Georgy I., Sergeev, Dmitry V., Pozharitskaya, Olga N., Esaulenko, Elena V., Kosman, Vera M., Makarov, Valery G.

    Published in Phytomedicine (Stuttgart) (15-07-2011)
    “…The hepatoprotective effect of birch bark extract (BBE) in patients with chronic hepatitis C (CHC) was studied. Forty-two patients with serologically confirmed…”
    Get full text
    Journal Article
  12. 12

    Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19 by Sabitov, A U, Lioznov, D A, Zhdanov, K V, Tikhonova, E P, Esaulenko, E V, Kovtun, O P, Kuznetsov, P L, Sorokin, P V

    Published in Terapevtic̆eskii arhiv (03-06-2024)
    “…To evaluate the efficacy and safety of riamilovir in the treatment of COVID-19 in adults. The study included 180 patients with a laboratory-confirmed diagnosis…”
    Get full text
    Journal Article
  13. 13

    Сlinical and immunological status of patients with chronic hepatitis С on the background of comorbidity by Basina, Valentina V., Dzemova, Aleksandra A., Arsent’eva, Natalya A., Novak, Kseniya E., Esaulenko, Elena V., Totolyan, Areg A.

    Published in Consilium medicum (Online) (2021)
    “…Aim. To study the clinical and immunological features of the course of chronic hepatitis C (CHC) in patients with an unfavorable comorbid background. Materials…”
    Get full text
    Journal Article
  14. 14

    CYTOKINES, CHEMOKINES AND GROWTH FACTORS ASSOCIATED WITH CHRONIC VIRAL HEPATITIS C by Natalia A. Arsentieva, Oleg K. Batsunov, Natalia E. Lyubimova, Valentina V. Basina, Elena V. Esaulenko, Areg A. Totolian

    Published in Medit͡s︡inskai͡a︡ immunologii͡a (01-08-2019)
    “…Chronic hepatitis C (CHC) represents a significant public health concern. In the majority of cases, the infection progresses to a chronic form, which is…”
    Get full text
    Journal Article
  15. 15

    Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea by Boumbaly, S., Balde, T.A. L., Semenov, A. V., Ostankova, Yu. V., Serikova, E. N., Naidenova, E. V., Valutite, D. E., Shchemelev, A. N., Zueva, E. B., Esaulenko, E. V., Totolian, Areg A.

    Published in Voprosy virusologiĭ (15-03-2022)
    “…Introduction. The problem of transfusion safety in relation to parenteral viral hepatitis still remains relevant. Viral hepatitis B (HB) remains the most…”
    Get full text
    Journal Article
  16. 16

    Infective endocarditis in a series of 1527 autopsies: clinical-pathology correlations by De Rosa, Francesco Giuseppe, Shaparova, Galina A, Riccardo, Flavia, Esaulenko, Elena V

    Published in Le infezioni in medicina (01-12-2002)
    “…The study of 1527 autopsies showed that in 2% of cases the cause of death was Infective Endocarditis (IE) (acute in the absolute majority), mostly not…”
    Get full text
    Journal Article
  17. 17